Abstract
Aim
To clarify the role of leptin in women with polycystic ovary syndrome (PCOS), we analyzed whether serum leptin levels correlate with other hormonal parameters in obese and non-obese women with PCOS.
Methods
We studied 20 obese (body mass index, BM ≥25kg/ m2) and 20 non-obese (BMI < 25kg/m2) women with PCOS diagnosed by the existence of menstrual disturbance, elevated serum level of luteinizing hormone (LH) with normal follicle-stimulating hormone (FSH) and the characteristic polycystic appearance of the ovaries on transvaginal ultrasound images. Blood samples for LH, FSH, estradiol, testosterone (T), androstenedione (Δ4) and leptin were obtained, and the relationships between variables were examined by calculating Spearman correlation coefficients.
Results
Mean levels of leptin, T and Δ4 in obese PCOS women were significantly higher than those in non-obese PCOS women, but this was not the case for BMI, bodyweight and waist to hip ratio. In all the 40 PCOS women considered together, there were significant positive correlations of leptin with BMI, waist to hip ratio, and Δ4 levels. However, in each group separately, serum leptin levels in obese PCOS women correlated only with BMI and bodyweight, whereas serum leptin levels in non-obese PCOS women correlated with serum Δ4 levels.
Conclusion
Although further study is needed to assess the role of leptin on ovarian function in non-obese women with PCOS, present findings do not support the fact that leptin is involved in the development of hormonal abnormalities in obese women with PCOS.
Similar content being viewed by others
References
Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1995; 30: 478–479.
Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543–546.
Campfield LA, Smith FJ, Guisez Y et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546–549.
Maffei M, Halaas J, Ravussin E et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 11: 1155–1161.
Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295.
Ma Z, Gingerich RL, Santiago JV et al. Radioimmunoassay of leptin in human plasma. Clin Chem 1996; 42: 942–946.
Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996; 12: 318–320.
Barash IA, Cheung CC, Weigle DS et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996; 137: 3144–3147.
Yu WH, Kimura M, Walczewska A et al. Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci USA 1997; 94: 1023–1028.
Chehab FF, Mounzih K, Lu R et al. Early onset of reproductive function in normal female mice treated with leptin. Science 1997; 275: 88–90.
Zachow RJ, Magoffin DA. Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology 1997; 138: 847–850.
Agarwal SK, Vogel K, Weitsman SR et al. Leptin antagonizes the insulin-like growth factor-I augmentation of steroido-genesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 1999; 84: 1072–1076.
Spicer LJ, Chamberlain CS, Francisco CC. Ovarian action of leptin: effects on insulin-like growth factor-I-stimulated function of granulosa and thecal cells. Endocrine 2000; 12: 53–59.
Kikuchi N, Kazurnichi A, Mizunuma H et al. Inhibitory action of leptin on early follinular growth differs in immature and adult female mine. Biol Reprod 2001; 65: 66–71.
Brzechffa PR, Jakimiuk AJ, Agarwal SK et al. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 91: 4166–4169.
Micic D, Macut D, Popovic V et al. Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome. Gynecol Endocrinol 1997; 11: 315–320.
Mantzoros CS, Dunaif A, Flier JS. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 1687–1691.
Laughlin GA, Morales AJ, Yen SS. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab 1997; 82: 1692–1696.
Rouru J, Anttila L, Koskinen P et al. Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 1697–1700.
Chapman IM, Wittert GA, Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf) 1997; 46: 175–191.
Gennarelli G, Holte J, Wide L et al. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome? Hum Reprod 1998; 13: 535–541.
Adams J, Poison DW, Francs S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986; 293: 335–359.
Andoh K, Mizunuma H, Liu X et al. A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome. Fertil-Steril 1998; 70: 840–846.
Vicennati V, Gambineri A, Calzoni F et al. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Metabolism 1998; 47: 988–992.
Hamilton FD, Kiddy D, Watson H et al. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotropin. Br J Obstet Gynaecol 1992; 99: 128–131.
Fedorcsak P, Dale PO, Storeng R et al. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic: ovarian syndrome. Hum Reprod 2001; 16: 1086–1091.
Rebar R, Judd HL, Yen SSC et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 1976; 57: 1320–1326.
Minanni SL, Marcondes J, Bernardo L et al. Analysis of gonadotropin pulsatility in hirsute women with normal menstrual cycles and in women with polycystic ovary syndrome. Fertil Steril 1999; 71: 675–683.
Sir-Petermann T, Piwonka V, Perez F et al. Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome? Hum Reprod 1999; 14: 1435–1439.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kikuchi, N., Andoh, K., Mizunuma, H. et al. Relationships between circulating leptin concentrations and other hormonal parameters in obese and non-obese women with polycystic ovary syndrome. Reprod Med Biol 1, 49–54 (2002). https://doi.org/10.1046/j.1445-5781.2002.00008.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1046/j.1445-5781.2002.00008.x